CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX)

CUSIP: 171757107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Stock
Total 13F shares
17,674,910
Share change
-897,611
Total reported value
$41,473,007
Price per share
$2.35
Number of holders
49
Value change
-$7,058,607
Number of buys
16
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 171757107?
CUSIP 171757107 identifies CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q4 2018

As of 31 Dec 2018, CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,674,910 shares. The largest 10 holders included BVF INC/IL, BB BIOTECH AG, Omega Fund Management, LLC, INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, Opaleye Management Inc., Aisling Capital LLC, Vanguard Group Inc, Alethea Capital Management, LLC, and Monashee Investment Management LLC. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.